NorthWest Biotherapeutics Inc (NWBO)

[newman2021]

Great idea! How comes no one has thought about it so far? Lets do it. I remember SRPT AdCom where FDA's Woodcock listened to the parents and she approved the drug even though there was not enough data to conclusively prove that the drug works. At the same time she killed Amarin's Anchor trial as data not sufficient but became political savvy to accept insufficient SRPT data. SRPT conducts more trials for expanded indications but never able to prove the drug works well, imo. In contrast, we have a big fat tail of OS curve into 5+ yrs.